May 09, 2012
Kuo Tong spoke at the American Cytogenetics Conference on April 19, 2012 at the Sheraton Gunter Hotel, San Antonio, TX. The subject involved the evolving molecular coding and reimbursement landscape.
May 09, 2012
Kuo Tong is schedule to speak at the Washington State Biomedical Device Summit on Thursday, June 14 at the University of Washington Bothell Campus.
March 06, 2012
Cost analysis comparing adjuvant epimacular brachytherapy with anti-VEGF monotherapy for the management of neovascular age-related macular degeneration. EMB combined with anti-VEGF treatment has the potential to yield considerable cost savings, compared with anti-VEGF monotherapy.
January 01, 2012
The cost-effectiveness associated with continuous flow LVADs for destination therapy has improved significantly relative to the pulsatile flow devices. This change is explained by significant improvements in survival, functional status and reduction in implantation costs.
August 24, 2011
The objective of this session is to understand how regulatory, reimbursement, and commercialization activities were developed for a new therapy and a companion diagnostic. Specific milestones and timelines will be discussed so that the audience can benchmark their own experiences and future plans. Next Generation Dx Summit, Washington D.C. August 25, 2011
August 24, 2011
A recent prospective, randomized controlled trial demonstrated that a continuous flow (CF) left ventricular assist device (LVAD) resulted in improved survival at 12 and 24months compared to a pulsatile-flow (PF) device. The current study examines the hospitalization costs associated with treatment of New York Heart Failure Class IV patients when implanted with a CF LVAD and compares them to previously reported costs of a PF LVAD in the same population. Journal of Cardiac Surgery August 2011
July 14, 2011
Clinical Ophthalmology: July 2011; Evaluation of economic efficiencies in clinical retina practice: activity-based cost analysis and modeling to determine impacts of changes in patient management.
The purpose of this study is to report the use of activity-based cost analysis to identify areas of practice efficiencies and inefficiencies within a large academic retinal center and a small single-specialty group.
2011 Clinical Ophthalmology
May 26, 2011
2011 ASCO Annual Meeting: Abstract “Trends in utilization of oncology drugs for Medicare fee-for-service beneficiaries from 2002 through 2009” is published as part of the 2011 Annual Meeting of the American Society of Clinical Oncology. The abstract is available on www.asco.org and Journal of Clinical Oncology
May 17, 2011
MARCH 11, 2011: An article entitled “ The burden of disease of retinal vein occlusion: review of the literature”, coauthored by Marianne Laouri, Er Chen, and Mark Looman, is published in EYE RVO_Lit_Review_Laouri_2011_Eye.pdf
April 15, 2011
Kuo Bianchini Tong, MS, Founder and CEO, Quorum Consulting, Inc, is a panelist at the 2011 BayBio Annual Conference in Burlingame on April 21st.
Private and government-sponsored healthcare reimbursement plans are quickly becoming the dominant forces in the healthcare market. The payers have the power of the purse and thus increasingly the power over which products advance to the market and which products are shelved. This is quickly becoming a key financing issue, as buyers of assets want to see the value proposition based on how the product will be reimbursed. A panel of key hospital and healthcare insurance decision makers will provide insight into their decision making process and discuss what both commercial and pre-commercial companies need to factor into their product development plans in order to reach patients and to get reimbursed.
February 28, 2011
Kuo Bianchini Tong, Founder and CEO and Marianne Laouri, Ph.D., Practice Leader, Health Economics, Outcomes and Analytics at Quorum Consulting, Inc. present on issues surrounding clinical utlity and commercialization at CBI’s 6th Annual Forum on Medical Device and Diagnostics Reimbursement Strategies in San Diego February 23-24, 2011 at The Westin in San Diego, CA. Copies of presentations from the conference can be found at:
http://www.cbinet.com/compendiums/pc11192
December 27, 2010
July 30, 2010
July 29, 2010
July 26, 2010
June 30, 2010
June 09, 2010
May 03, 2010
May 03, 2010
February 25, 2010
February 08, 2010
Quorum Consulting, Inc. is the proud sponsor of:
5th Forum on Medical Device and Diagnostics Reimbursement Strategies
Ensuring Favorable Coverage, Coding and Payment Decisions Based on Clinical and Health Economic Evidence
February 23 - 24, 2010
San Diego, CA
Marianne Laouri, Ph.D., Practice Leader for Health Economics and Analytic Services will be co-leading a workshop titled, “Develop a Health Economics Program Early in Your Commercialization Strategy.”
Workshop Objective:
Quantifying the overall economic benefits that your product brings to the healthcare system is an increasingly important part of positioning it for a positive coverage decision for any size company. Commercial and private payors want to understand the net benefit an innovation brings to the healthcare system and expect data that validates the ROI of using your product to be available upon request. In this workshop, explore the importance and integration of health economics early in a commercialization strategy, the development of effective health models and techniques for communicating value to payors.
Please contact Quorum if you have not registered for the conference and would like to benefit from a $300 discount for registration.
January 18, 2010
December 11, 2009
November 30, 2009
Quorum is pleased to announce a recent publication entitled Costs and Rehabilitation Use of Stoke Survivors: A Retrospective Study of Medicare Beneficiaries in the September-October 2009 issue of Topic in Stroke Rehabilitation. Article Link
November 13, 2009
The BioExec Institute is an internationally-renowned executive program delivered by leaders in the industry for life sciences directors and VP-level managers searching for the keys to managing business trade-offs within a highly regulated and competitive industry. Delivered by industry specialists, including Deloitte LLP leaders and BioExec Institute faculty and alumni, the Institute offers attendees six-days of interactive programming from September through December 2009, including three evening networking receptions. Participants have unique opportunities to debate the strategies and tactics of business leadership within biopharma and will complete the program with invaluable insight and powerful networks to help them deliver bottom-line value in this growing industry.
November 05, 2009
The National Institute of Health Commercialization Program (NIH-CAP) is a nation wide program funded by NIH designed to assist a preselected group of the most promising SBIR Phase II-funded life science companies bring their technologies to market. The November 18 meeting will launch the 10 month long 2009-2010 NIH CAP. At the meeting Susan will discuss reimbursement strategy development and tactical planning methods and concepts that have been designed to ensure that participating companies have a successful CAP experience and outcome.
Nov. 18, 2009, 3:30-4:30pm
Marriott Marina Del Rey, Marina Del Rey, CA
November 02, 2009
A recent study in Cancer cited findings from a Quorum presentation at the 2007 ASCO Breast Cancer Symposium. Referencing the ASCO presentation, the article states that up to 66% of eligible patients had no documentation of HER-2 testing in claims records. This critical finding suggests a need for more evidence to support decision-making on emerging diagnostic technologies in cancer care. Cancer 2009 and Her-2 Poster
October 31, 2009
Astia is a San Francisco-based accelerator dedicated to supporting women-led high growth start-ups in the life sciences, clean tech and high technology sectors. The “Doing it Right Program” is one of several Astia programs offered annually that are designed to support women-led start ups who want to become dominant players in their sectors. During her presentation Susan will review key reimbursement strategic decisions that start up companies need to determine prior to meeting with angels, VCs and Corporate Investors. Susan will also review a framework to help the companies make these important reimbursement decisions.
Microsoft, 835 Market Street, 7th floor, San Francisco 94123
November, 4, 2009, 10:30am-1pm
August 06, 2009
Quorum helps a client navigate the CMS application process to secure additional payment to hospital customers for its technology, effective fiscal year 2010.
CMS Website
July 30, 2009
Nicole Coustier, Director of Payer Relations and Government Affairs, attends the hospital outpatient APC Panel meeting at CMS in Baltimore, Aug 5-7 2009.
CMS Website
June 29, 2009
Strategic investment and product development considerations need to incorporate both reimbursement and patient payment options.how to think about the consumer market in reimbursement strategies. If anyone wants to take a look, you can find it at this link: With the rise of consumer control in healthcare expenditures, many medical technology companies have focused their business strategies around out-of-pocket spending as opposed to third-party reimbursement. Through case studies, we identified three scenarios surrounding consumer-targeted business models. These include: targeting consumer payment for some indications of a product while getting covered by insurers for other indications; targeting consumers solely because of belief that coverage will not be granted; and attempting to get coverage, but forced to pursue out-of-pocket spending after failing. As a result of the recession, companies that rely only on consumers for revenue are threatened, but this does not mean that targeting this market is not a valid choice. Thinking strategically about how your product will be viewed by insurers and consumers and how to market it to these two groups is an extremely important business decision.
June 23, 2009
In the June 2009 issue of Retinal Physician, President Kuo Tong participates in a round table discussion on the application of activity-based costing analyses to three retina practices. Quorum conducts the analysis for each practice to examine the profitability of core retina service lines or activities, highlighting the effects of changing practice patterns and reimbursement scenarios in the retina subspecialty.
Retinal Physician Website
Practice Efficiency CME Study PDF
June 22, 2009
Senior Consultant Barbara Santry, serves as the moderator for the panel discussion ‘Who Will Pay For Healthcare Unbound?’ The panel highlights how to negotiate the legacy definition of a covered service: i.e. a medically necessary service to diagnose or treat an illness.
Healthcare Unbound Brochure
May 21, 2009
Director Nicole Coustier presents on the sponsors role in clinical trial reimbursement at the MAGI conference in Miami, FL , May 31-June 3, 2009
May 20, 2009
Quorum Consulting presents a poster entitled “Cost effectiveness of targeting chemotherapy with the 70-gene prognostic signature in early stage breast cancer patients” at the 45th ASCO Annual Meeting in Orlando, FL, May 29-31, 2009.
ASCO Website
ASCO Podcast
May 04, 2009
Recognizing the gap between wireless information technologies that are commonly used in other industries and the systems used by healthcare facilities across the country and by the pharmaceutical sector, the Wireless-Life Sciences Alliance is conducting its annual Wireless-Life Sciences Convergence Summit.
Join senior executives at this two-day, action-packed educational summit for an intensely ongoing and expanding dialogue about the convergence of wireless technologies, the life sciences, and consumers. Attendees will include: business, medical and scientific companies, academia, entrepreneurs, and capital sources.
New this year....Day Two of the Convergence Summit will be open to the wider wireless life sciences community. Titled “Commercializing Wireless Life Sciences Technology Successfully,” this day is designed for individuals with technology that could be adapted for life sciences or who are already entering the segment. You will learn about the customers; how insurers think; how clinical efficacy is best established; managing the FDA, and how to access non-traditional capital sources. Kuo Tong will present on reimbursement strategies for wireless life sciences technology company during this break out session.
May 01, 2009
Kuo Tong, Quorum’s President is hosting a networking event in San Francisco on Monday May 11. The event is an opportunity to hear from industry leaders and network with executives and professionals who will play a role in shaping the future of health care.
Penn Club of Northern California
February 09, 2009
Kuo Tong, Quorum’s Founder and President, is interviewed on the PricewaterhouseCoopers Start Up Show, and discusses the future of reimbursement for new medical technologies in the era of given health care reform, CMS payment policies, and other changes in the US health care system.
January 20, 2009
Sleep Apnea Incidence and Outcomes in Heart Failure Patients: A Retrospective Study of Medicare Beneficiaries, a collaborative research between Quorum and key opinion leaders, will be presented at the 58th American College of Cardiology Annual Scientific Session, March 29-31, 2009 in Orlando, Florida.
January 01, 2009
Quorum’s Kuo Tong gives a presentation on “Treatment Patterns and Costs of Lumbar Spinal Stenosis from 2003-2005” at the Orthopaedic Research Society (ORS) 55th Annual Meeting, February 22-25, 2009 in Las Vegas, Nevada. ORS Website
September 22, 2008
In Vitro Diagnostic Regulatory & Reimbursement Conference provides guidance for efficient regulatory pathways, compliance and clinical research, exploring health economics and cost-value relationships for the IVD industry.
September 29-30 2008
Baltimore, MD
Conference Website
September 08, 2008
September 17, 2008 in Dana Point, CA, Kuo and Barbara share case study examples of how Strategic Reimbursement Planning – which occurs throughout the product development cycle – can determine how expeditiously the FDA will approve a product and how much reimbursement/coverage will be provided by CMS and private payers. They overview the value of conducting a Reimbursement Assessment and developing a Reimbursement Strategy, and the other key elements involved in preparing for your product launch.
August 01, 2008
The AHA Scientific Sessions 2008 is the premier cardiovascular meeting that includes programming in three broad areas of clinical, basic and population science as well as cross-disciplinary translational science, it will be held November 8-12 in New Orleans, Louisiana.
June 10, 2008
Panel Discussion: Potential Collaboration Between Payers, Providers, and Manufacturers-Oppurtunities for Unbound Technologies
May 22, 2008
Presentation entitled, Costs and Rehabilitation of Stroke Patients: A Retrospective Study of Medicare Beneficiaries, given at the International Stroke Conference February 20-22, 2008 in New Orleans, LA.
March 17, 2008
This annual conference arms pharmaceutical companies with strategies for designing and maintaining their patient assistance programs to achieve optimal value and to maintain compliance. This meeting convenes executives from the pharmaceutical industry and from PAP foundations and clinics to create an excellent forum for exchange, networking and learning.
CBI’s 9th Patient Assistance Programs conference covers the changing regulatory environment, as well as operational and strategic issues for manufacturers to best structure, operate and remain compliant with their PAP.
Here, Quorum’s Bridget Metcalf and Nicole Coustier led a half day workshop on “The Fundamentals of Patient Assistance Programs”. The two presented a wide range of case studies displaying various types of PAPs, potential challenges, and the importance of using collected data to evolve PAP processes with the changing market, patient populations and payer environment.
Fundamentals_of_PAP_Programs.pdf
Case_Studies_in_PAP_Design.pdf
March 17, 2008
Quorum president and founder Kuo Tong gives a presentation at The National Academies in Washington, DC March 18th 2008. Hosted by the National Materials Advisory, this roundtable on Biomedical Engineering Materials and Applications (BEMA) is focused on identifying issues of significance related to biomaterials and the medical devices constructed from them. Mr. Tong’s presentation is focused specifically on the economics of device innovation and the effects on the patient.
February 20, 2008
Quorum’s Kuo Tong and Er Chen present an oral presentation on ‘Costs and Rehabilitation of Stoke Patients: A Retrospective Study of Medicare Beneficiaries’. The aim of the study, to examine the costs and PTR utilization in patients with stroke and stroke-related hemiparesis during a 3-year
period following their first stroke onset.
July 24, 2007
During the BIOMEDevice Forum, Quorum President, Kuo Bianchini Tong, will be chairing a panel discussion on Reimbursement. BIOMEDevice Forum is a two-day event, October 3 & 4. Kuo Tong’s panel discussion covering Reimbursement is slated for 11:45am on Thursday, October 4.
More on the BIOMEDevice Forum can be seen here: www.biomedeviceforum.com
July 18, 2007
CBI (the Center for Business Intelligence) holds its third annual conference in Orange County, CA, and is chaired by Quorum’s President, Kuo B. Tong; the full title of the conference is Medical Device and Diagnostics Reimbursement and Medicare Coverage The discussions bring together the industry’s leading experts in medical device and diagnostic reimbursement.
July 18, 2007
During the DxMA Seminar at AACC, Quorum President, Kuo Bianchini Tong, speaks on Medical Reimbursement Strategies.
The introduction to the DxMA Seminar at AACC is as follows:
This year, we’ll cover new ideas designed to generate more interest in your products, gain more trust from your audience, and drive diagnostics into the future. Topics will include reimbursement strategies, effectively using advocacy groups, and encouraging clinicians to adopt new tests and protocols. So, mark your calendar for July 18, and rescue your marketing while your head’s still above water.
A copy of the presentation is available here.
July 17, 2007
Quorum Consulting, Inc. president and founder, Kuo Tong, and senior consultant, Barbara Santry, present selected case studies on INR Monitoring and Telehealth products.
The Healthcare Unbound conference sponsored by The Center for Business Intelligence (TCBI) describes their conference as follows:
Consumer health care technologies are driving opportunities to serve patients in new ways and in new settings. Forrester Research recently coined the term “Healthcare Unbound” to encompass the trends toward self-care, mobile care, and home care. More specifically, Forrester describes “Healthcare Unbound” as “technology in, on and around the body that frees care from formal institutions.”
The program has a strong focus on the use of Remote Patient Monitoring (RPM) / Home Telehealth / Pervasive Computing technologies for wellness promotion and disease management.
May 16, 2007
Quorum presents two posters at this symposium which covers all aspects of basic and clinical
research, and provides a venue for discussion of the latest advances in understanding of myelodysplastic
syndromes.
March 02, 2007
Quorum’s Bridget Metcalf and Nicole Coustier give extensive workshops regarding Patient Assistant Programs (PAP). PAPs 101 highlights the key players and perspectives and the various safety-net health care providers. The workshop is about fundamentally understanding PAPs in the reimbrusement arena.
Workshop participants learn the nuts and bolts of PAPs in order to maintain compliance with regulations, navigate through the changing Part D landscape and to make sound operational decisions.
January 17, 2007
Kuo Tong, president and founder, speaks at the CBI Webinar on January 31, 2007 at 2:00-3:00pm EST. The online seminar covers topics on Medical Device and Diagnostics Reimbursement and Medicare Coverage like the CBI conference.
December 11, 2006
Quorum presents a topical seminar and leading a “Reimbursement 101” 3.5-hr workshop session at the CBI 2nd Annual Forum on Medical Device and Diagnostics Reimbursement and Medicare Coverage on December 11-12, 2006 in Orange County, CA.
The workshop will be held on the first day of the conference and will cover:
Identify Your Target Market for Reimbursement Planning
Understand How Providers Get Paid - An Overview of Coding and Payment
Key Strategies for Successful Reimbursement Planning
The topical seminar will be held on the second day of the conference and is titled:
“Leverage Economic Data to Drive Reimbursement Strategies.”
September 28, 2006
Quorum presents a poster at the poster session for the 46th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) at the Moscone Center in San Francisco, CA. The poster presentation was titled:
“Hospital Costs Of Esophageal Candidiasis: The Economic Impact of Esophageal Candidiasis within Hospital Expenditures Across Patient Subgroups.” Conference host: Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC).
September 28, 2006
Quorum presents at the poster session for the 46th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) at the Moscone Center in San Francisco, CA. The poster presentation is titled:
“Hospital Costs Of Esophageal Candidiasis: The Economic Impact of Esophageal Candidiasis within Hospital Expenditures Across Patient Subgroups.” [PDF, 18.6kb]
Conference host: Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC).Esophageal_Candidiasis_poster_Final_-_ICAAC_2006.pdf
September 06, 2006
On August 8th the Centers for Medicare and Medicaid Services (CMS) issued the Proposed Hospital Outpatient Prospective Payment System (HOPPS) Rule for FY2007:
“Proposed Changes to the Hospital Outpatient PPS and CY 2007 Rates.” [cms.hhs.gov]
In the proposed rule for the Hospital Outpatient PPS, CMS expanded the list of procedures that may be performed in Ambulatory Surgical Centers, added HCPCS codes to better describe hospital emergency visits, reimburse more accurately for drug administration, lowered the reimbursement rate for separately payable drugs to ASP + 5 and added requirements for the reporting of quality measures. More important that the addition of the 14 new ASC codes in 2007, CMS proposed to relax the requirements for a given procedures eligibility to be performed in an ASC to be those that can be done safely in that setting in 2008. ASC payment would be modified to reflect the relative weight calculation of the OPPS to remove site of service bias in facility fee reimbursement. Quorum can help clients understand how the changes to HOPPS may affect them and their customers.
September 06, 2006
Quorum presents a topical seminar and leads a “Reimbursement 101” 3.5-hr workshop session at the CBI 2nd Annual Forum on Medical Device and Diagnostics Reimbursement and Medicare Coverage on December 11-12, 2006 in Orange County, CA.
The workshop is held on the first day of the conference and covers:
* Identify Your Target Market for Reimbursement Planning
* Understand How Providers Get Paid - An Overview of Coding and Payment
* Key Strategies for Successful Reimbursement Planning
The topical seminar is held on the second day of the conference and is titled:
“Leverage Economic Data to Drive Reimbursement Strategies.”
Brochure: 2nd Annual Forum on Medical Device and Diagnostics Reimbursement and Medicare Coverage
Conference host: Center for Business Intelligence (CBI)
August 03, 2006
On August 1st the Centers for Medicare and Medicaid Services (CMS) issued the Final Hospital Inpatient Prospective Payment System (HIPPS) Rule for FY2007:
“Medicare Program: Final Changes to the Hospital Inpatient PPS and FY2007 Rates.” [cms.hhs.gov]
In the final Hospital Inpatient PPS CMS scaled back and delayed earlier proposed changes in Medicare payments to hospitals for fiscal year 2007. Based on estimated hospital costs rather than inflated charges, the 2007 payments will have improved accuracy. In the same vein, CMS also updated its method of estimating costs to include more data from high-cost hospitals. The resulting payment changes will be smaller than proposed in April and will be put into effect gradually over three years. Quorum can help clients understand how the changes to HIPPS may affect them and their customers.
Please contact us to learn more.
July 17, 2006
Quorum presents at the Third Annual Healthcare Unbound Conference and Exhibition held on July 17-18, 2006 at the Hyatt Regency Cambridge in Cambridge, MA. This is a visionary conference that looks to the convergence of consumer and healthcare technologies.
Special focus will be on remote monitoring and home telehealth. Consumer health care technologies are driving opportunities to serve patients in new ways and in new settings. Forrester Research recently coined the term “Healthcare Unbound” to encompass the trends toward self-care, mobile care, and home care. More specifically, Forrester describes “Healthcare Unbound” as “technology in, on and around the body that frees care from formal institutions.”
July 12, 2006
A manuscript co-authored by Quorum Consulting published in an upcoming issue of the Journal of Heart and Lung Transplantation. The title of the manuscript is:
“Hospital costs for left-ventricular assist devices for destination therapy: lower costs for implantation in the post-REMATCH era.”
June 27, 2006
The 46th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) held September 27-30th, 2006 in San Francisco, California includes a Quorum poster presentation on the:
“The Economic Impact of Esophageal Candidiasis within Hospital Expenditures Across Patient Subgroups.”
Conference host: Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC).
June 26, 2006
Quorum presents a poster abstract at the 2006 American Society of Health-systems Pharmacists (ASHP) Summer Meeting and Exhibition held June 25-28th, 2006 in Orlando, Florida. The abstract is entitled:
“The Economic Impact of Aspergillosis: Analysis of Hospital Expenditures Across Patient Subgroups.”
Conference host: American Society of Health-systems Pharmacists (ASHP)
ASHP_2006_poster_-_Aspergillosis_061206.pdf
June 25, 2006
Quorum’s Jason Cheng presents a poster at the 16th Congress of the International Society for Human and Animal Mycology (ISHAM) held June 25-29th, 2006 in Paris, France entitled “Cost-effectiveness analysis of anti-fungal prophylaxis in patients undergoing hematopoietic stem cell transplantation.”
Conference host: International Society for Human and Animal Mycology (ISHAM)
ISHAM_2006_poster_-_Mycamine_CEA_061506.pdf
June 06, 2006
Quorum submits a poster presentation at the 42nd ASCO Annual Meeting held this year at the Georgia World Congress Center in Atlanta, Georgia. The ASCO Annual Meeting is the premier event in the oncology community. The research and education presented at ASCO meetings enhance oncologists’ knowledge, advancing high-quality cancer care.
Our poster presentation is on the “Incidence, Costs of Care, and Mortality of Medicare Beneficiaries Diagnosed with Cancer of Unknown Primary Origin.”
March 30, 2006
Quorum Consulting attendings the following 2006 HCPCS Public Meetings:
Tuesday, April 25, 2006 (durable medical equipment)
Wednesday, April 26, 2006 (orthotics and prosthetics, day 1)
Thursday, April 27, 2006 (orthotics and prosthetics, day 2)
Thursday, May 4, 2006 (supplies, day 1)
Friday, May 5, 2006 (supplies, day 2)
Thursday, May 11, 2006 (drug and biologicals, day 1)
Friday, May 12, 2006 (drug and biologicals, day 2)
March 06, 2006
Quorum presents a lecture on designing a PAP at CBI’s 7th Annual Conference on Patient Assistance Programs on March 6-7, 2006. In this era of Medicare-covered outpatient prescription drugs, manufacturers are faced with new questions regarding where their patient assistance programs fit into the revised patient-access model. The Medicare program provides some guidance; the Office of the Inspector General provides some guidance; and manufacturers are left to sort it out. How can PAPs remain available to patients who need them, and still be compliant with all applicable federal regulations? Quorum participates in this recent CBI conference to present considerations in designing a PAP that makes sense for products in question, and to discuss with industry leaders the nuances and challenges facing manufacturer PAPs today.
November 23, 2005
Quorum Consulting presents a poster at the 45th annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). The poster is on display at ICAAC in Washington DC on December 16-19, 2005. The title of the presentation is:
“Cost Effectiveness Analysis of Combined Phenotype and Genotype Drug Resistance Testing versus Genotyping Alone”
July 11, 2005
Quorum presents at The Second Annual Healthcare Unbound Conference and Exhibition sponsored by The Center for Business Innovation (TCBI) in Boston, MA on July 11-12, 2005.
The Healthcare Unbound conference is a meeting of healthcare providers and medical device manufacturers focusing primarily on the use of remote monitoring, home telehealth, and pervasive computing technologies for wellness promotion and disease management. As these innovations become more commonplace in medical management, there will be an increasing demand for third-party payer coverage (government and private insurance) of new medical technologies. Quorum’s presentation focuses on inherent challenges and opportunities in seeking third-party payer coverage for “healthcare unbound” products. The meeting’s title is “A Primer on Securing Reimbursement from Payers for Healthcare Unbound Products and Services”
June 21, 2005
Quorum co-authors an economic assessment of topical immunomodulators for treatment of atopic dermatitis which is published in PharmacoEconomics. PharmacoEconomics is a peer-reviewed journal addressing optimum drug therapy and health outcomes via pharmacoeconomic and quality-of-life assessments. The article is titled “The Economics of Topical Immunomodulators for the Treatment of Atopic Dermatitis”
February 22, 2005
Quorum attends the Current Procedural Terminology (CPT) Editorial Panel Meeting on February 10 through 13 in Newport Beach, California. This panel, which meets at least four times per year, is made up of 17 physicians representing various medical and surgical specialties and third-party payers. The Editorial Panel is responsible for enacting changes to CPT coding language.
February 09, 2005
In June 2005, Quorum presents at the Inaugural Executive Summit on Medical Device Reimbursement and Medicare Coverage, sponsored by The Center for Business Intelligence. The following topics are presented:
“Identify the Steps to an Effective Reimbursement Assessment”
“Effectively Collect Valuable and Appropriate Economic Data”
February 08, 2005
In February 2005, Quorum participates in the Workshop for Financial Coordinators, sponsored by the Transplant Financial Coordinators Association (TFCA). Quorum is part of a panel discussion on patient assistance programs and the impact the Medicare Reform bill may have on the futures of these programs.
Subscribe